Mackay Shields LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-34,892
Closed -$17.1M 391
2022
Q1
$17.1M Sell
34,892
-1,371
-4% -$627K 0.15% 157
2021
Q4
$16.8M Sell
36,263
-990
-3% -$416K 0.14% 172
2021
Q3
$13.9M Sell
37,253
-1,421
-4% -$540K 0.13% 175
2021
Q2
$14.8M Sell
38,674
-35,101
-48% -$13.4M 0.14% 171
2021
Q1
$26.5M Sell
73,775
-32,647
-31% -$10.5M 0.19% 104
2020
Q4
$34.2M Sell
106,422
-13,833
-12% -$4.25M 0.24% 79
2020
Q3
$32.3M Buy
120,255
+5,609
+5% +$1.51M 0.22% 85
2020
Q2
$30.1M Buy
114,646
+1,218
+1% +$325K 0.24% 85
2020
Q1
$25.8M Sell
113,428
-18,166
-14% -$4.95M 0.24% 94
2019
Q4
$39.7M Sell
131,594
-4,499
-3% -$1.24M 0.27% 78
2019
Q3
$32.7M Buy
136,093
+79,575
+141% +$21.8M 0.2% 120
2019
Q2
$15.9M Sell
56,518
-30,549
-35% -$8.34M 0.11% 215
2019
Q1
$25M Buy
87,067
+13,062
+18% +$3.78M 0.18% 124
2018
Q4
$19.4M Buy
+74,005
New +$20.3M 0.16% 160
2018
Q3
Sell
-85,176
Closed -$20.3M 1173
2018
Q2
$20.3M Sell
85,176
-52,874
-38% -$12.2M 0.14% 188
2018
Q1
$30.3M Buy
+138,050
New +$32.4M 0.19% 121

Other funds holding ELV

Mackay Shields LLC's ELV Position: Q2 2022 in Review

Mackay Shields LLC sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 34,892 shares — an estimated $17.1M sold.

Mackay Shields LLC first reported a position in ELV in Q1 2018 and held it in 16 quarters. The position peaked at $39.7M in Q4 2019. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Mackay Shields LLC reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 34,892 Elevance Health shares in Q2 2022, an estimated $17.1M.
  • Mackay Shields LLC first reported a position in Elevance Health in Q1 2018 and held it in 16 quarters.
  • Mackay Shields LLC's Elevance Health position peaked at $39.7M in Q4 2019.
  • 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.